Subscribe to RSS
DOI: 10.1055/s-0040-1716915
Improving Transitional Services for Adolescents and Young Adults with Epilepsy and Intellectual Disability
Funding None.![](https://www.thieme-connect.de/media/10.1055-s-00029025/202004/lookinside/thumbnails/10-1055-s-0040-1716915_2000061-1.jpg)
Abstract
The transition from pediatric to adult health care systems is challenging for many adolescents with epilepsy and their families, and those challenges are compounded for adolescents with comorbid intellectual disabilities and epilepsy (ID-E). Many traditional transition pathways to adult care are inadequate, as they fail to address important considerations unique to the ID-E population or are absent entirely. Poor organization of care during critical transition periods increases the risks of sudden unexpected death in epilepsy, suboptimal seizure control, inadequate management of comorbidities, and poor psychological and social outcomes. The literature lacks systematic studies on effective transition programs for this population. The present review provides an overview of the main themes important in care transitions for the ID-E population: (1) precise diagnosis and management of seizures; (2) mental health and medical comorbidities affecting care; (3) accessing behavioral, habilitative, legal, financial, and community resources; and (4) caretaker support. We propose a specific framework which includes targeted recommendations of minimum care standards for youth with ID-E transitioning to adult care.
Keywords
epilepsy - transition - intellectual disability - adolescent - genetics - behavioral comorbidity - transition readinessPublication History
Received: 26 July 2020
Accepted: 12 August 2020
Article published online:
09 October 2020
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Camfield C, Camfield P. Preventable and unpreventable causes of childhood-onset epilepsy plus mental retardation. Pediatrics 2007; 120 (01) e52-e55
- 2 Fry AE, Rees E, Thompson R. et al. Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy. BMC Med Genet 2016; 17 (01) 34
- 3 Pescosolido MF, Gamsiz ED, Nagpal S, Morrow EM. Distribution of disease-associated copy number variants across distinct disorders of cognitive development. J Am Acad Child Adolesc Psychiatry 2013; 52 (04) 414-430.e14
- 4 Hochstenbach R, Buizer-Voskamp JE, Vorstman JA, Ophoff RA. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. Cytogenet Genome Res 2011; 135 (3-4): 174-202
- 5 Hepburn CM, Cohen E, Bhawra J, Weiser N, Hayeems RZ, Guttmann A. Health system strategies supporting transition to adult care. Arch Dis Child 2015; 100 (06) 559-564
- 6 Devinsky O, Asato M, Camfield P. et al. Delivery of epilepsy care to adults with intellectual and developmental disabilities. Neurology 2015; 85 (17) 1512-1521
- 7 Camfield PR, Andrade D, Camfield CS. et al. How can transition to adult care be best orchestrated for adolescents with epilepsy?. Epilepsy Behav 2019; 93: 138-147
- 8 Thompson R, Laxhman N. Impact of epilepsy and intellectual disabilities on family life. In: Prasher VP, Kerr M. eds. Epilepsy and Intellectual Disabilities. Springer International Publishing; 2016: 317-328
- 9 Prior M, McManus M, White P, Davidson L. Measuring the “triple aim” in transition care: a systematic review. Pediatrics 2014; 134 (06) e1648-e1661
- 10 Young C, Shankar R, Palmer J. et al. Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk?. Seizure 2015; 25: 112-116
- 11 Andrade DM, Bassett AS, Bercovici E. et al. Epilepsy: transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force. Epilepsia 2017; 58 (09) 1502-1517
- 12 Camfield P, Camfield C, Pohlmann-Eden B. Transition from pediatric to adult epilepsy care: a difficult process marked by medical and social crisis. Epilepsy Curr 2012; 12 (Suppl. 03) 13-21
- 13 Franklin MS, Beyer LN, Brotkin SM, Maslow GR, Pollock MD, Docherty SL. Health care transition for adolescent and young adults with intellectual disability: views from the parents. J Pediatr Nurs 2019; 47: 148-158
- 14 Cooley WC, Sagerman PJ. American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians, Transitions Clinical Report Authoring Group. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics 2011; 128 (01) 182-200
-
15
Transitions from pediatric epilepsy to adult epilepsy care,
Adolescent with significant developmental disability (independence unlikely).
Accessed May 5, 2020 at: https://www.aesnet.org/sites/default/files/file_attach/ClinicalResources/PracticeTools/Transtoolsadolescents/AESTransitionsPracticeTool-devdelayedFinalApproved4-21-132.pdf
- 16 Brown LW, Camfield P, Capers M. et al. The neurologist's role in supporting transition to adult health care: a consensus statement. Neurology 2016; 87 (08) 835-840
-
17
GotTransition.org,
Got Transition® - Researchers & Policymakers,
GotTransition.org.
Accessed May 15, 2020. Available at: https://www.gottransition.org/researchpolicy/index.cfm
- 18 Geerlings RPJ, Aldenkamp AP, Gottmer-Welschen LMC. et al. Evaluation of a multidisciplinary epilepsy transition clinic for adolescents. Eur J Paediatr Neurol 2016; 20 (03) 385-392
- 19 Nabbout R, Camfield CS, Andrade DM. et al. Treatment issues for children with epilepsy transitioning to adult care. Epilepsy Behav 2017; 69: 153-160
- 20 Nabbout R, Teng T, Chemaly N, Breuillard D, Kuchenbuch M. Transition of patients with childhood onset epilepsy: perspectives from pediatric and adult neurologists. Epilepsy Behav 2020; 104 (Pt A): 106889
-
21
Individuals with disabilities education act, 20 U.S.C. § 1400 et seq.
Accessed December 3, 2004 at: https://www.congress.gov/108/plaws/publ446/PLAW-108publ446.pdf
-
22
Americans With Disabilities Act, 42 U.S.C. § 12101–12213 (1995).
Accessed 1995 at: https://uscode.house.gov/view.xhtml?path=/prelim@title42/chapter126&edition=prelim
-
23
Motwani M.
The ADA and IDEA basics: inclusion of children with disabilities,
Exch Early Child Lead Mag.
Accessed 2007 at: https://eric.ed.gov/?id=EJ755707
-
24
Wagner M,
Newman L,
Cameto R,
Garza N,
Levine P.
After high school: a first look at the postschool experiences of youth with disabilities,
A report from the national longitudinal transition study-2 (NLTS2).
2005 . Accessed May 5, 2020 at: https://eric.ed.gov/?id=ED494935
- 25 Grigal M, Hart D, Migliore A. Comparing the transition planning, postsecondary education, and employment outcomes of students with intellectual and other disabilities. Career Dev Except Individ 2011; 34 (01) 4-17
-
26
Turning rights into reality: how guardianship and alternatives impact the autonomy of people with intellectual and developmental disabilities,
national council on disability.
Accessed June 10, 2019 at: https://ncd.gov/publications/2019/turning-rights-into-reality
- 27 Leo RJ. Competency and the capacity to make treatment decisions: a primer for primary care physicians. Prim Care Companion J Clin Psychiatry 1999; 1 (05) 131-141
- 28 Jameson JM, Riesen T, Polychronis S. et al. Guardianship and the potential of supported decision making with individuals with disabilities. Res Pract Persons Severe Disabl 2015; 40 (01) 36-51
- 29 Blanck P, Martinis JG. “The right to make choices”: the national resource center for supported decision-making. Inclusion 2015; 3 (01) 24-33
- 30 Saaltink R, MacKinnon G, Owen F, Tardif-Williams C. Protection, participation and protection through participation: young people with intellectual disabilities and decision making in the family context. J Intellect Disabil Res 2012; 56 (11) 1076-1086
- 31 Gilleland J, Amaral S, Mee L, Blount R. Getting ready to leave: transition readiness in adolescent kidney transplant recipients. J Pediatr Psychol 2012; 37 (01) 85-96
- 32 Sawicki GS, Lukens-Bull K, Yin X. et al. Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ--Transition Readiness Assessment Questionnaire. J Pediatr Psychol 2011; 36 (02) 160-171
- 33 Nowinski CJ, Victorson D, Cavazos JE, Gershon R, Cella D. Neuro-QOL and the NIH Toolbox: implications for epilepsy. Therapy 2010; 7 (05) 533-540
- 34 Borlot F, Tellez-Zenteno JF, Allen A, Ali A, Snead III OC, Andrade DM. Epilepsy transition: challenges of caring for adults with childhood-onset seizures. Epilepsia 2014; 55 (10) 1659-166
- 35 Salm M, Abbate K, Appelbaum P. et al. Use of genetic tests among neurologists and psychiatrists: knowledge, attitudes, behaviors, and needs for training. J Genet Couns 2014; 23 (02) 156-163
- 36 Kerr M, Linehan C, Brandt C. et al. Behavioral disorder in people with an intellectual disability and epilepsy: a report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE. Epilepsia Open 2016; 1 (3-4): 102-111
- 37 Turky A, Felce D, Jones G, Kerr M. A prospective case control study of psychiatric disorders in adults with epilepsy and intellectual disability. Epilepsia 2011; 52 (07) 1223-1230
- 38 Moeschler JB, Shevell M. Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics 2014; 134 (03) e903-e918
- 39 Battaglia A, Doccini V, Bernardini L. et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol 2013; 17 (06) 589-599
- 40 Mullen SA, Carvill GL, Bellows S. et al. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 2013; 81 (17) 1507-1514
- 41 American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), American Psychiatric Publication. 2013
- 42 Espie CA, Watkins J, Curtice L. et al. Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry 2003; 74 (11) 1485-1492
- 43 Fridhandler JD, Coelho FM, Tai P, Jette N, Andrade DM. A comparison of antiepileptic drug therapy in patients with severe intellectual disability and patients with normal intellect. Epilepsy Behav 2012; 25 (02) 196-199
- 44 Brandt C, Lahr D, May TW. Cognitive adverse events of topiramate in patients with epilepsy and intellectual disability. Epilepsy Behav 2015; 45: 261-264
- 45 Ettinger AB, Weisbrot DM, Saracco J, Dhoon A, Kanner A, Devinsky O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998; 39 (08) 874-877
- 46 Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE. Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav 2008; 13 (03) 535-541
- 47 Kerr MP, Baker GA, Brodie MJ. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy Behav 2005; 7 (03) 472-480
- 48 Harrison P, Oakland T. ABAS-3: Adaptive behavior assessment system. Los Angel, CA: West Psychol Serv; 2015
- 49 Carvill GL, Weckhuysen S, McMahon JM. et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 2014; 82 (14) 1245-1253
- 50 Makela NL, Birch PH, Friedman JM, Marra CA. Parental perceived value of a diagnosis for intellectual disability (ID): a qualitative comparison of families with and without a diagnosis for their child's ID. Am J Med Genet A 2009; 149A (11) 2393-2402
- 51 Derose KP, Escarce JJ, Lurie N. Immigrants and health care: sources of vulnerability. Health Aff (Millwood) 2007; 26 (05) 1258-1268
-
52
Andrulis DP,
Brach C.
Integrating Literacy, Culture, and Language to Improve Health Care Quality for Diverse Populations.
Published August 2007. Accessed May 11, 2020 at: https://www.ingentaconnect.com/content/png/ajhb/2007/00000031/a00100s1/art00016
- 53 Kossoff EH, Henry BJ, Cervenka MC. Transitioning pediatric patients receiving ketogenic diets for epilepsy into adulthood. Seizure 2013; 22 (06) 487-489
- 54 D'Andrea Meira I, Romão TT, Pires do Prado HJ, Krüger LT, Pires MEP, da Conceição PO. Ketogenic diet and epilepsy: what we know so far. Front Neurosci 2019; 13: 5
- 55 Kossoff EH, Zupec-Kania BA, Auvin S. et al. Charlie Foundation, Matthew's Friends, Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018; 3 (02) 175-192
- 56 Nei M, Ngo L, Sirven JI, Sperling MR. Ketogenic diet in adolescents and adults with epilepsy. Seizure 2014; 23 (06) 439-442
- 57 McLaughlin RM, Schraegle WA, Nussbaum NL, Titus JB. Parental coping and its role in predicting health-related quality of life in pediatric epilepsy. Epilepsy Behav 2018; 87: 1-6